Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management

S Sukumar, B Lämmle, SR Cataland - Journal of clinical medicine, 2021 - mdpi.com
Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy
characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and …

Prevalence of E. coli O157: H7 in water sources: an overview on associated diseases, outbreaks and detection methods

T Saxena, P Kaushik, MK Mohan - Diagnostic microbiology and infectious …, 2015 - Elsevier
Escherichia coli O157: H7 is a zoonotic pathogen with its ability to cause human illness
ranging from diarrheal disease to fatal hemolytic uremic syndrome. E. coli O157: H7 had …

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

M Scully, BJ Hunt, S Benjamin… - British journal of …, 2012 - search.ebscohost.com
The article focuses on providing guidelines to healthcare professionals for the diagnosis of
various types and sub groups of Thrombotic thrombocytopenic purpura (TTP), occurring …

[PDF][PDF] Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

SL Allford, BJ Hunt, P Rose… - British journal of …, 2003 - redbook.streamliners.co.nz
Thrombotic thrombocytopenic purpura (TTP) was first described by Moschowitz (1924). The
classic pentad of diagnostic features has been recognized for many years. However, several …

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

M Rieger, PM Mannucci, JAK Hovinga, A Herzog… - Blood, 2005 - ashpublications.org
Autoantibodies neutralizing human ADAMTS13 (a disintegrin-like and metalloproteinase
with thrombospondin type 1 motif), the metalloprotease that physiologically cleaves von …

Management of thrombotic thrombocytopenic purpura: current perspectives

P Blombery, M Scully - Journal of blood medicine, 2014 - Taylor & Francis
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic
microangiopathy which causes significant morbidity and mortality unless promptly …

Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan

M Matsumoto, Y Fujimura, H Wada, K Kokame… - International journal of …, 2017 - Springer
Thrombotic thrombocytopenic purpura (TTP) can rapidly progress into a life-threatening
condition, thus the importance of appropriate diagnosis and treatment cannot be overstated …

[HTML][HTML] Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic …

Y Benhamou, C Assié, PY Boelle, M Buffet… - …, 2012 - ncbi.nlm.nih.gov
Background Acquired thrombotic thrombocytopenic purpura is still associated with a 10–
20% death rate. It has still not been possible to clearly identify early prognostic factors of …

Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand

LC Fox, SJ Cohney, JY Kausman, J Shortt… - Internal medicine …, 2018 - Wiley Online Library
Thrombotic microangiopathy (TMA) arises in a variety of clinical circumstances with the
potential to cause significant dysfunction of the kidneys, brain, gastrointestinal tract and …

Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic …

P Blombery, L Kivivali, D Pepperell… - Internal Medicine …, 2016 - Wiley Online Library
Background Thrombotic thrombocytopenic purpura (TTP) is a rare, life‐threatening
thrombotic microangiopathy (TMA). In 2009, the Australian TTP/TMA registry was …